(Q42879123)

English

Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis

scientific article published on 10 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis (English)

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

Refractory anemia with ring sideroblasts

0 references

Torsten Haferlach

5

object named as

Torsten Haferlach

1 reference

Europe PubMed Central

9 November 2017

PMC publication ID

Claudia Haferlach

6

object named as

Claudia Haferlach

1 reference

Europe PubMed Central

9 November 2017

PMC publication ID

Susanne Schnittger

3

object named as

Susanne Schnittger

1 reference

Europe PubMed Central

9 November 2017

PMC publication ID

2

object named as

Frank Dicker

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

Alexander Kohlmann

4

object named as

Alexander Kohlmann

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

author name string

Johanna Flach

1

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

publication date

10 November 2009

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

95

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

3

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

518-519

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

Acquired mutations in TET2 are common in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

27 May 2018

Mutation in TET2 in myeloid cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

27 May 2018

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

27 May 2018

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

27 May 2018

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

27 May 2018

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

16 August 2018

Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

16 August 2018

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

16 August 2018

UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

16 August 2018

JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

16 August 2018

TET2 mutations in myelodysplasia and myeloid malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833086

1 December 2018

Identifiers

10.3324/HAEMATOL.2009.013631

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42879123&oldid=1973103668"